406 related articles for article (PubMed ID: 38473905)
1. Novel Perspectives in Chronic Kidney Disease-Specific Cardiovascular Disease.
Xu C; Tsihlis G; Chau K; Trinh K; Rogers NM; Julovi SM
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473905
[TBL] [Abstract][Full Text] [Related]
2. Cardiorenal syndrome type 4: From chronic kidney disease to cardiovascular impairment.
Granata A; Clementi A; Virzì GM; Brocca A; de Cal M; Scarfia VR; Zanoli L; Ronco C; Corrao S; Malatino L
Eur J Intern Med; 2016 May; 30():1-6. PubMed ID: 26961461
[TBL] [Abstract][Full Text] [Related]
3. Long-term impact of cardiorenal syndromes on major outcomes based on their chronology: a comprehensive French nationwide cohort study.
Halimi JM; de Fréminville JB; Gatault P; Bisson A; Gueguen J; Goin N; Sautenet B; Maisons V; Herbert J; Angoulvant D; Fauchier L
Nephrol Dial Transplant; 2022 Nov; 37(12):2386-2397. PubMed ID: 35438794
[TBL] [Abstract][Full Text] [Related]
4. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.
Jungbauer CG; Uecer E; Stadler S; Birner C; Buchner S; Maier LS; Luchner A
Nephrology (Carlton); 2016 Jun; 21(6):490-8. PubMed ID: 26422793
[TBL] [Abstract][Full Text] [Related]
5. Vasculopathy in the setting of cardiorenal syndrome: roles of protein-bound uremic toxins.
Guo J; Lu L; Hua Y; Huang K; Wang I; Huang L; Fu Q; Chen A; Chan P; Fan H; Liu ZM; Wang BH
Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H1-H13. PubMed ID: 28411233
[TBL] [Abstract][Full Text] [Related]
6. Cardiorenal syndrome type 4: management.
Clementi A; Virzì GM; Brocca A; de Cal M; Vescovo G; Granata A; Ronco C
Blood Purif; 2013; 36(3-4):200-9. PubMed ID: 24496191
[TBL] [Abstract][Full Text] [Related]
7. Proteomic Biomarkers in the Cardiorenal Syndrome: Toward Deciphering Molecular Pathophysiology.
He T; Zhang Z; Staessen JA; Mischak H; Latosinska A; Beige J
Am J Hypertens; 2021 Aug; 34(7):669-679. PubMed ID: 33821948
[TBL] [Abstract][Full Text] [Related]
8. Cardiorenal Syndrome and the Role of the Bone-Mineral Axis and Anemia.
Charytan DM; Fishbane S; Malyszko J; McCullough PA; Goldsmith D
Am J Kidney Dis; 2015 Aug; 66(2):196-205. PubMed ID: 25727384
[TBL] [Abstract][Full Text] [Related]
9. Negotiating renal dysfunction when treating patients with heart failure.
Carubelli V; Metra M; Lund LH
Expert Rev Cardiovasc Ther; 2018 Feb; 16(2):113-122. PubMed ID: 29292652
[TBL] [Abstract][Full Text] [Related]
10. Chronic kidney disease and cardiovascular complications.
Di Lullo L; House A; Gorini A; Santoboni A; Russo D; Ronco C
Heart Fail Rev; 2015 May; 20(3):259-72. PubMed ID: 25344016
[TBL] [Abstract][Full Text] [Related]
11. Uremic toxins in chronic kidney disease highlight a fundamental gap in understanding their detrimental effects on cardiac electrophysiology and arrhythmogenesis.
van Ham WB; Cornelissen CM; van Veen TAB
Acta Physiol (Oxf); 2022 Nov; 236(3):e13888. PubMed ID: 36148604
[TBL] [Abstract][Full Text] [Related]
12. Cardiorenal Nexus: A Review With Focus on Combined Chronic Heart and Kidney Failure, and Insights From Recent Clinical Trials.
McCullough PA; Amin A; Pantalone KM; Ronco C
J Am Heart Assoc; 2022 Jun; 11(11):e024139. PubMed ID: 35616212
[TBL] [Abstract][Full Text] [Related]
13. Cardiorenal syndrome type 4: insights on clinical presentation and pathophysiology from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).
Tumlin JA; Costanzo MR; Chawla LS; Herzog CA; Kellum JA; McCullough PA; Ronco C
Contrib Nephrol; 2013; 182():158-73. PubMed ID: 23689661
[TBL] [Abstract][Full Text] [Related]
14. [Vascular dysfunction in Cardiorenal Syndrome type 4].
Sessa C; Granata A; Gaudio A; Xourafa A; Malatino L; Lentini P; Fatuzzo P; Rapisarda F; Castellino P; Zanoli L
G Ital Nefrol; 2020 Feb; 37(1):. PubMed ID: 32068357
[TBL] [Abstract][Full Text] [Related]
15. Cardiorenal syndrome type 4: A study of cardiovascular diseases in chronic kidney disease.
H S; B S A; Moger V; Swamy M
Indian Heart J; 2017; 69(1):11-16. PubMed ID: 28228293
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association.
Zoccali C; Mallamaci F; Adamczak M; de Oliveira RB; Massy ZA; Sarafidis P; Agarwal R; Mark PB; Kotanko P; Ferro CJ; Wanner C; Burnier M; Vanholder R; Wiecek A
Cardiovasc Res; 2023 Sep; 119(11):2017-2032. PubMed ID: 37249051
[TBL] [Abstract][Full Text] [Related]
17. Recent Developments in the Evaluation and Management of Cardiorenal Syndrome: A Comprehensive Review.
Kim JA; Wu L; Rodriguez M; Lentine KL; Virk HUH; Hachem KE; Lerma EV; Kiernan MS; Rangaswami J; Krittanawong C
Curr Probl Cardiol; 2023 Mar; 48(3):101509. PubMed ID: 36402213
[TBL] [Abstract][Full Text] [Related]
18. Micronutrients and cardiorenal disease: insights into novel assessments and treatment.
McCullough PA
Blood Purif; 2011; 31(1-3):177-85. PubMed ID: 21228587
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease.
Matsushita K; Ballew SH; Wang AY; Kalyesubula R; Schaeffner E; Agarwal R
Nat Rev Nephrol; 2022 Nov; 18(11):696-707. PubMed ID: 36104509
[TBL] [Abstract][Full Text] [Related]
20. Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure.
Ronco C; Cicoira M; McCullough PA
J Am Coll Cardiol; 2012 Sep; 60(12):1031-42. PubMed ID: 22840531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
